The results of a new clinical trial published in the journal STEM CELLS Translational Medicine demonstrate how a topical solution made up of stem cells leads to the regrowth of hair for people with a common type of baldness.1
Getting to the root of the problem
Having a head of hair is probably something that many people don’t give much of a second thought to. But for individuals experiencing androgenetic alopecia (AGA), also referred to as male or female-pattern baldness, losing one’s hair can adversely impact self-esteem, psychological wellbeing and quality of life.
AGA is a complex condition that has genetic, hormonal and environmental roots. It affects approximately 50% of all males and a similar proportion of females, however the pattern of hair loss differs between the sexes. In women, hair often becomes thinner all over the head and the hairline does not recede. Often in women, AGA does not lead to total baldness.
In males, hair loss often occurs in a pattern, beginning above both temples and eventually receding to form an “M” shape. In most cases, AGA progresses to partial or complete baldness.
Unfortunately, there are only a few FDA-approved medications to treat hair loss, and these carry a myriad of associated side effects including a negative impact on sexual functioning. There is therefore a pertinent need to develop anti-hair loss treatments that lack such side effects.
Emerging research has demonstrated the potential application of stem cells, particularly adipose tissue-derived stem